Synacthene Retard

Synacthene Retard is a prolonged-release injectable containing tetracosactide, a synthetic corticotropin analog used for adrenal function testing and certain inflammatory conditions. This EU-manufactured product supports cortisol stimulation and diagnostic clarity. Ideal for clinics and patients requiring extended-release corticotropin therapy.

Tetracosactide, the active ingredient in Synacthene Retard, is primarily used to assess adrenal function by stimulating cortisol production. It is also employed in managing inflammatory conditions where corticotropin therapy is indicated, such as severe allergic reactions or certain autoimmune disorders. Patients often ask what is Synacthene Retard used for in diagnostic and therapeutic contexts.

Synacthene Retard provides a gradual release of tetracosactide, supporting sustained adrenal stimulation over time. Users may experience effects related to cortisol modulation, such as improved energy levels or reduced inflammation in treated conditions. Effects vary by individual and underlying health status.

Synacthene Retard should be handled by healthcare professionals due to its injectable nature and potential systemic effects. Store below 25°C and protect from light. Patients with infections, diabetes, or osteoporosis should use with caution. Always follow medical guidance for administration and monitoring.

Concurrent use with corticosteroids may enhance effects, while certain diuretics or insulin may require dose adjustments. Alcohol and tobacco can influence adrenal response. Always disclose all medications to your healthcare provider before starting Synacthene Retard to avoid unintended interactions.